Covid-19 vaccine: Bharat Biotech confirms adverse event during Covaxin phase 1 trial reported within 24 hours

The adverse event occurred in a 35-year old participant with no co-morbidities, who was part of Phase 1 trials at a site in western India.

from Latest News https://www.dnaindia.com/india/report-covid-19-vaccine-bharat-biotech-covaxin-adverse-incident-phase-1-trial-reported-2857839